Advertisement
Screener

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets

2.7 / 5 stars · 63/118 Roast Me

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets of $4.34 million as of 2025-12-27, per its 10-K filed 2026-02-18.

Financial Statements › Notes › Compensation Related Costs › Retirement Benefits › Defined Benefit Plan › Defined Benefit Plan, Additional Information

us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets · last filed 2026-02-18

  • 2025-12-27: Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets $4.34M.
  • 2024-12-28: Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets $3.55M.
  • 2023-12-30: Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets $3.50M.
  • 2022-12-31: Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets $3.11M.
Period endDefined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets
2025-12-27$4.34M
10-K · filed 2026-02-18
2024-12-28$3.55M
10-K · filed 2026-02-18
2023-12-30$3.50M
10-K · filed 2025-02-19
2022-12-31$3.11M
10-K · filed 2024-02-14
2021-12-25$19.50M
10-K · filed 2023-02-22
2020-12-26$18.56M
10-K · filed 2022-02-16
2019-12-28$343.69M
10-K · filed 2021-02-17
2018-12-29$213.25M
10-K · filed 2020-02-11
2017-12-30$292.15M
10-K · filed 2019-02-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
INCYTE CORP (INCY)United States$24.855B13.14
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B
FOXO TECHNOLOGIES INC. (FOXO)United States$0.000B-277.71